HRT Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

HRT Financial’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.74M	Buy	+55,225	New	+$5.88M	0.01%	913
2025 Q2	–	Sell	-2,380	Closed	-$216K	–	3349
2025 Q1	$216K	Sell	2,380 -3,198	-57%	-$288K	﹤0.01%	1970
2024 Q4	$481K	Buy	+5,578	New	+$505K	﹤0.01%	1462
2024 Q3	–	Sell	-8,031	Closed	-$734K	–	2984
2024 Q2	$734K	Buy	+8,031	New	+$717K	﹤0.01%	1137
2024 Q1	–	Sell	-46,430	Closed	-$3.78M	–	2916
2023 Q4	$3.78M	Buy	46,430 +18,884	+69%	+$1.48M	0.03%	401
2023 Q3	$2.2M	Buy	+27,546	New	+$2.22M	0.02%	579
2023 Q2	–	Sell	-67,098	Closed	-$5.21M	–	3095
2023 Q1	$5.21M	Buy	67,098 +62,036	+1,226%	+$4.78M	0.06%	252
2022 Q4	$393K	Sell	5,062 -40,941	-89%	-$3.02M	0.01%	1577
2022 Q3	$3.09M	Buy	46,003 +2,952	+7%	+$217K	0.03%	451
2022 Q2	$3.31M	Buy	+43,051	New	+$3.36M	0.04%	377

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

HRT Financial's PPH Position: Q1 2026 in Review

HRT Financial opened a new position in VanEck Pharmaceutical ETF (PPH) in Q1 2026: 55,225 shares worth $5.74M. The stake represents 0.01% of the portfolio and ranks #913 among its holdings. This is a return to the name: HRT Financial previously reported a position in PPH as recently as Q1 2025.

HRT Financial first reported a position in PPH in Q2 2022 and has held it in 10 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

HRT Financial held 55,225 shares of VanEck Pharmaceutical ETF worth $5.74M as of Q1 2026.
VanEck Pharmaceutical ETF was a new HRT Financial position in Q1 2026.
VanEck Pharmaceutical ETF made up 0.01% of HRT Financial's portfolio in Q1 2026, its #913 holding.
HRT Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and has held it in 10 quarters since.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.